Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Concussion | 53 | 2024 | 53 | 16.540 |
Why?
|
| Athletic Injuries | 40 | 2024 | 42 | 12.360 |
Why?
|
| Sports | 25 | 2024 | 43 | 9.140 |
Why?
|
| Football | 18 | 2022 | 24 | 5.030 |
Why?
|
| Sports Medicine | 17 | 2024 | 19 | 4.920 |
Why?
|
| Humans | 85 | 2024 | 14077 | 2.480 |
Why?
|
| Exercise | 10 | 2024 | 203 | 1.620 |
Why?
|
| Athletes | 11 | 2023 | 20 | 1.450 |
Why?
|
| Soccer | 4 | 2021 | 10 | 1.180 |
Why?
|
| Medicine | 2 | 2023 | 3 | 0.980 |
Why?
|
| Femoracetabular Impingement | 2 | 2014 | 2 | 0.950 |
Why?
|
| Pandemics | 4 | 2023 | 280 | 0.900 |
Why?
|
| Achilles Tendon | 2 | 2021 | 2 | 0.890 |
Why?
|
| Tendinopathy | 2 | 2021 | 3 | 0.890 |
Why?
|
| Mental Health | 1 | 2024 | 86 | 0.870 |
Why?
|
| Chiropractic | 1 | 2022 | 1 | 0.860 |
Why?
|
| Clinical Competence | 2 | 2021 | 13 | 0.810 |
Why?
|
| Platelet-Rich Plasma | 1 | 2021 | 2 | 0.780 |
Why?
|
| Consensus | 8 | 2023 | 59 | 0.780 |
Why?
|
| Developing Countries | 1 | 2024 | 385 | 0.760 |
Why?
|
| Peer Review | 1 | 2021 | 1 | 0.760 |
Why?
|
| Child | 16 | 2024 | 2180 | 0.700 |
Why?
|
| Neuropsychological Tests | 5 | 2020 | 55 | 0.630 |
Why?
|
| Decision Making | 1 | 2019 | 52 | 0.620 |
Why?
|
| Case-Control Studies | 8 | 2023 | 464 | 0.600 |
Why?
|
| Brain Injury, Chronic | 2 | 2014 | 3 | 0.580 |
Why?
|
| Post-Concussion Syndrome | 1 | 2017 | 1 | 0.570 |
Why?
|
| Terminology as Topic | 1 | 2017 | 10 | 0.570 |
Why?
|
| Craniocerebral Trauma | 2 | 2012 | 6 | 0.530 |
Why?
|
| Adult | 14 | 2024 | 5664 | 0.510 |
Why?
|
| Bicycling | 1 | 2015 | 6 | 0.510 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 1 | 0.500 |
Why?
|
| Societies, Medical | 1 | 2015 | 23 | 0.490 |
Why?
|
| Physicians | 1 | 2015 | 30 | 0.490 |
Why?
|
| Abdominal Pain | 2 | 2014 | 7 | 0.480 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 49 | 0.470 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 18 | 0.470 |
Why?
|
| Safety | 1 | 2014 | 34 | 0.460 |
Why?
|
| Congresses as Topic | 6 | 2018 | 20 | 0.450 |
Why?
|
| Leadership | 1 | 2013 | 20 | 0.450 |
Why?
|
| Adolescent | 13 | 2024 | 2858 | 0.450 |
Why?
|
| Early Diagnosis | 4 | 2015 | 80 | 0.440 |
Why?
|
| Convalescence | 1 | 2012 | 2 | 0.430 |
Why?
|
| Professional Practice | 1 | 2012 | 4 | 0.420 |
Why?
|
| Male | 15 | 2022 | 6489 | 0.370 |
Why?
|
| Neck Injuries | 3 | 2014 | 4 | 0.340 |
Why?
|
| Berlin | 6 | 2018 | 6 | 0.340 |
Why?
|
| South Africa | 9 | 2024 | 7312 | 0.320 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2022 | 190 | 0.320 |
Why?
|
| Personality | 2 | 2017 | 2 | 0.300 |
Why?
|
| Polymorphism, Genetic | 3 | 2018 | 96 | 0.290 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2019 | 42 | 0.280 |
Why?
|
| Female | 13 | 2023 | 8751 | 0.250 |
Why?
|
| Psychiatry | 1 | 2024 | 5 | 0.240 |
Why?
|
| Forecasting | 1 | 2024 | 20 | 0.230 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2013 | 4 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 123 | 0.230 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 2 | 2013 | 10 | 0.230 |
Why?
|
| Mental Disorders | 1 | 2024 | 40 | 0.220 |
Why?
|
| Brain Injuries | 1 | 2023 | 3 | 0.220 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 14 | 0.220 |
Why?
|
| Dementia | 1 | 2023 | 16 | 0.220 |
Why?
|
| Comprehension | 1 | 2022 | 5 | 0.220 |
Why?
|
| Anxiety | 1 | 2023 | 39 | 0.210 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2022 | 1 | 0.210 |
Why?
|
| Tendon Injuries | 1 | 2022 | 1 | 0.210 |
Why?
|
| Eye Movements | 2 | 2019 | 2 | 0.210 |
Why?
|
| Delphi Technique | 4 | 2023 | 28 | 0.200 |
Why?
|
| Bayes Theorem | 1 | 2022 | 77 | 0.200 |
Why?
|
| Exercise Therapy | 1 | 2021 | 13 | 0.190 |
Why?
|
| Return to Sport | 2 | 2023 | 3 | 0.190 |
Why?
|
| First Aid | 1 | 2021 | 6 | 0.190 |
Why?
|
| Ultrasonography | 1 | 2021 | 77 | 0.190 |
Why?
|
| Vaccination | 1 | 2022 | 347 | 0.180 |
Why?
|
| Video Recording | 1 | 2020 | 1 | 0.180 |
Why?
|
| Youth Sports | 1 | 2020 | 2 | 0.180 |
Why?
|
| Apolipoprotein E4 | 2 | 2017 | 4 | 0.170 |
Why?
|
| Eye Movement Measurements | 1 | 2019 | 1 | 0.170 |
Why?
|
| Data Collection | 2 | 2023 | 86 | 0.160 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 1377 | 0.160 |
Why?
|
| Reward | 1 | 2018 | 2 | 0.160 |
Why?
|
| Smartphone | 1 | 2018 | 4 | 0.160 |
Why?
|
| tau Proteins | 1 | 2018 | 7 | 0.160 |
Why?
|
| Genotype | 5 | 2018 | 430 | 0.160 |
Why?
|
| Mobile Applications | 1 | 2018 | 12 | 0.160 |
Why?
|
| Incidence | 4 | 2022 | 655 | 0.150 |
Why?
|
| Apoptosis | 1 | 2018 | 39 | 0.150 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2017 | 1 | 0.150 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2017 | 2 | 0.150 |
Why?
|
| Harm Reduction | 1 | 2017 | 7 | 0.150 |
Why?
|
| Biomechanical Phenomena | 2 | 2014 | 9 | 0.150 |
Why?
|
| Inflammation | 1 | 2018 | 103 | 0.150 |
Why?
|
| Abscess | 2 | 1994 | 3 | 0.140 |
Why?
|
| Semantics | 1 | 2017 | 1 | 0.140 |
Why?
|
| Syndrome | 1 | 2017 | 19 | 0.140 |
Why?
|
| Symptom Assessment | 1 | 2017 | 15 | 0.140 |
Why?
|
| Internationality | 1 | 2017 | 34 | 0.140 |
Why?
|
| Emergency Treatment | 2 | 2013 | 13 | 0.140 |
Why?
|
| Recreation | 1 | 2016 | 4 | 0.130 |
Why?
|
| Career Choice | 1 | 2016 | 7 | 0.130 |
Why?
|
| Physical Examination | 2 | 2013 | 10 | 0.130 |
Why?
|
| Athletic Performance | 1 | 2015 | 6 | 0.130 |
Why?
|
| Running | 1 | 2015 | 6 | 0.130 |
Why?
|
| Altitude | 1 | 2015 | 9 | 0.130 |
Why?
|
| Risk Factors | 3 | 2014 | 1431 | 0.130 |
Why?
|
| Anthropometry | 1 | 2015 | 101 | 0.120 |
Why?
|
| Arthroscopy | 1 | 2014 | 1 | 0.120 |
Why?
|
| Groin | 1 | 2014 | 1 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 102 | 0.120 |
Why?
|
| Musculoskeletal Pain | 1 | 2014 | 2 | 0.120 |
Why?
|
| Neck Muscles | 1 | 2014 | 2 | 0.120 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2014 | 2 | 0.120 |
Why?
|
| Radiography | 1 | 2014 | 80 | 0.120 |
Why?
|
| Program Development | 1 | 2014 | 32 | 0.120 |
Why?
|
| Brain Damage, Chronic | 1 | 2014 | 2 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2014 | 53 | 0.120 |
Why?
|
| Myositis | 1 | 1993 | 3 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2014 | 55 | 0.110 |
Why?
|
| Social Media | 1 | 2014 | 6 | 0.110 |
Why?
|
| Risk Management | 1 | 2013 | 4 | 0.110 |
Why?
|
| Program Evaluation | 1 | 2014 | 89 | 0.110 |
Why?
|
| Collagen Type V | 1 | 2013 | 1 | 0.110 |
Why?
|
| Collagen Type XII | 1 | 2013 | 1 | 0.110 |
Why?
|
| Collagen Type XI | 1 | 2013 | 1 | 0.110 |
Why?
|
| Diffusion of Innovation | 1 | 2012 | 10 | 0.100 |
Why?
|
| Safety Management | 1 | 2012 | 4 | 0.100 |
Why?
|
| Injury Severity Score | 1 | 2011 | 4 | 0.100 |
Why?
|
| Glasgow Coma Scale | 1 | 2011 | 4 | 0.100 |
Why?
|
| Neuroimaging | 1 | 2011 | 5 | 0.100 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 4 | 0.100 |
Why?
|
| Checklist | 1 | 2011 | 5 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 532 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2011 | 35 | 0.100 |
Why?
|
| Young Adult | 4 | 2018 | 2357 | 0.090 |
Why?
|
| Health Promotion | 2 | 2024 | 108 | 0.090 |
Why?
|
| Seizures | 2 | 2023 | 20 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2022 | 1131 | 0.080 |
Why?
|
| Trauma Severity Indices | 2 | 2018 | 4 | 0.080 |
Why?
|
| Risk | 2 | 2017 | 87 | 0.070 |
Why?
|
| Guidelines as Topic | 2 | 2016 | 40 | 0.070 |
Why?
|
| Haplotypes | 2 | 2018 | 119 | 0.060 |
Why?
|
| Gene Frequency | 2 | 2017 | 117 | 0.060 |
Why?
|
| Social Responsibility | 1 | 2024 | 12 | 0.060 |
Why?
|
| Retirement | 1 | 2023 | 1 | 0.060 |
Why?
|
| Dizziness | 1 | 2023 | 2 | 0.060 |
Why?
|
| Headache | 1 | 2023 | 7 | 0.060 |
Why?
|
| Neck Pain | 1 | 2023 | 3 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2023 | 33 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2023 | 64 | 0.050 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2022 | 1 | 0.050 |
Why?
|
| Purines | 1 | 2022 | 2 | 0.050 |
Why?
|
| Rupture | 1 | 2022 | 3 | 0.050 |
Why?
|
| Cognition | 1 | 2023 | 75 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2022 | 40 | 0.050 |
Why?
|
| Age Factors | 2 | 2013 | 364 | 0.050 |
Why?
|
| Biomarkers | 1 | 2023 | 322 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2021 | 13 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 101 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 210 | 0.050 |
Why?
|
| Reference Standards | 1 | 2020 | 29 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2023 | 939 | 0.040 |
Why?
|
| Time and Motion Studies | 1 | 2020 | 3 | 0.040 |
Why?
|
| Public Health | 1 | 2021 | 122 | 0.040 |
Why?
|
| United States | 1 | 2020 | 129 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 9 | 0.040 |
Why?
|
| Motivation | 1 | 2018 | 56 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2018 | 33 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2018 | 50 | 0.040 |
Why?
|
| Personality Tests | 1 | 2017 | 1 | 0.040 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 2 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 247 | 0.040 |
Why?
|
| Self Report | 1 | 2017 | 111 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2017 | 132 | 0.040 |
Why?
|
| Alleles | 1 | 2017 | 134 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2017 | 119 | 0.030 |
Why?
|
| Societies | 1 | 2016 | 1 | 0.030 |
Why?
|
| Musculoskeletal System | 1 | 2016 | 1 | 0.030 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2014 | 3 | 0.030 |
Why?
|
| Actinomycosis | 1 | 1994 | 1 | 0.030 |
Why?
|
| Uterine Diseases | 1 | 1994 | 1 | 0.030 |
Why?
|
| Cutaneous Fistula | 1 | 1994 | 1 | 0.030 |
Why?
|
| Intestinal Fistula | 1 | 1994 | 2 | 0.030 |
Why?
|
| Intrauterine Devices | 1 | 1994 | 9 | 0.030 |
Why?
|
| Thigh | 1 | 1993 | 2 | 0.030 |
Why?
|
| Protective Devices | 1 | 2013 | 1 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2013 | 6 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2013 | 5 | 0.030 |
Why?
|
| Environment | 1 | 2013 | 21 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2013 | 24 | 0.030 |
Why?
|
| Aggression | 1 | 2013 | 13 | 0.030 |
Why?
|
| Emergencies | 1 | 2013 | 16 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 34 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 1 | 0.030 |
Why?
|
| Brain Edema | 1 | 2013 | 1 | 0.030 |
Why?
|
| Unconsciousness | 1 | 2013 | 1 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2013 | 11 | 0.030 |
Why?
|
| Australia | 1 | 2013 | 46 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 26 | 0.030 |
Why?
|
| Acute Disease | 1 | 2013 | 105 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2013 | 56 | 0.030 |
Why?
|
| Sex Factors | 1 | 2013 | 224 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2013 | 100 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 1675 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2013 | 217 | 0.030 |
Why?
|
| Time Factors | 1 | 2013 | 503 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 867 | 0.020 |
Why?
|
| Drainage | 1 | 1994 | 2 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1994 | 9 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1994 | 25 | 0.010 |
Why?
|
| Postmenopause | 1 | 1994 | 11 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1994 | 274 | 0.010 |
Why?
|
| Middle Aged | 1 | 1994 | 3425 | 0.000 |
Why?
|